These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11708164)

  • 41. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 42. HIV phenotype & genotype data highlights Lake Maggiore meeting.
    Este JA; Clotet B
    J Int Assoc Physicians AIDS Care; 1998 Sep; 4(9):60-3. PubMed ID: 11365800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Resistance to nucleoside reverse transcriptase inhibitors].
    Leal M; Santamaría JM
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055
    [No Abstract]   [Full Text] [Related]  

  • 44. [HIV mutant M184V. Benefits of a mutation].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():53-4. PubMed ID: 11373783
    [No Abstract]   [Full Text] [Related]  

  • 45. Human immunodeficiency viruses and drug therapy: resistance and implications for antiretroviral therapy.
    Idemyor V
    Pharmacotherapy; 2002 May; 22(5):659-62. PubMed ID: 12013369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance testing grows more prevalent in U.S.
    AIDS Alert; 1998 Sep; 13(9):103-4. PubMed ID: 11365787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV resistance testing proves its value.
    Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance testing: a primer for clinicians.
    Erbelding EJ
    Hopkins HIV Rep; 1999 May; 11(3):1, 8-9. PubMed ID: 11367369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversibility of HIV drug resistance.
    Davenport MP
    Science; 2000 May; 288(5470):1299. PubMed ID: 10847833
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.
    Friedman SR; Wainberg MA; Drucker E
    AIDS; 1998 Nov; 12(16):2089-93. PubMed ID: 9833849
    [No Abstract]   [Full Text] [Related]  

  • 51. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 52. [Light and shade on the treatment of HIV infection].
    Takata N
    Rinsho Ketsueki; 2001 Jun; 42(6):476-80. PubMed ID: 11505526
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV in Europe--a growing threat.
    Wahren B
    J Clin Virol; 2001 May; 21(2):171-3. PubMed ID: 11417524
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiretroviral resistance in clinical practice.
    Geretti AM; Easterbrook P
    Int J STD AIDS; 2001 Mar; 12(3):145-53. PubMed ID: 11231866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HIV susceptibility determination: a qualified position against regarding a complex technology].
    Telenti A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):45-6. PubMed ID: 11428060
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacoresistance: an emerging clinical problem.
    Carosi G
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
    [No Abstract]   [Full Text] [Related]  

  • 57. Current insights into reverse transcriptase inhibitor-associated resistance.
    Wainberg MA; White AJ
    Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
    [No Abstract]   [Full Text] [Related]  

  • 58. HIV drug resistance: overview of clinical data.
    Miller V
    J HIV Ther; 2001 Aug; 6(3):68-71. PubMed ID: 11555740
    [No Abstract]   [Full Text] [Related]  

  • 59. ICAAC eyes PIs, NNRTIs, and STIs.
    Mascolini M
    IAPAC Mon; 2000 Dec; 6(12):362-75. PubMed ID: 11299547
    [No Abstract]   [Full Text] [Related]  

  • 60. [Resistance in HIV therapy. Which cases profit from resistance testing].
    Manegold C
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():26-30. PubMed ID: 11373772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.